Acta Scientific Otolaryngology (ASOL) (ISSN: 2582-5550)

Perspective Volume 5 Issue 3

Platelet Rich Plasma in SNHL

Brajpal Tyagi* and Manika Teotia

Department of ENT, Harsh ENT Hospital, India

*Corresponding Author: Brajpal Tyagi, Department of ENT, Harsh ENT Hospital, India.

Received: January 26, 2023; Published: February 15, 2023

In India, deafness is the most common disability accounting of more than 6.3 million sufferers. It has been estimated that four in every 1000 children suffer from severe to profound hearing loss. Around 100,000 babies are in-born with this disability. The estimated childhood onset deafness was found to be 2-4% [1,2].


  1. Varshney S. “Deafness in India”. Indian Journal of Otology2 (2016): 73-76.
  2. Davey S., et al. “Impact of indian public health standards for rural health care facilities on national programme for control of deafness in India: The results of a cohort study”. Journal of Family Medicine and Primary Care 4 (2018): 780-786.
  3. Tyagi BBPS and Rout M. “Platelet rich plasma (PRP): a revolu­tionary treatment of sensorineural hearing loss”. Acta Scien­tific Otolaryngology 4 (2019): 2-5.
  4. Dohan Ehrenfest DM., et al. “Classification of platelet concentrates (Platelet-Rich Plasma-PRP, Platelet-Rich Fibrin-PRF) for topical and infiltrative use in orthopedic and sports medicine: current consensus, clinical implications and perspectives”. Muscles Ligaments Tendons Journal1 (2014): 3-9.
  5. Bear ZW and Mikulec AA. “Intratympanic steroid therapy for treatment of idiopathic sudden sensorineural hearing loss”. Missouri Medicine 111 (2014): 352‐356.
  6. Fradis M., et al. “Treatment of Meniere’s disease by intratym­panic injection with lidocaine”. Archives of Otolaryngology 8 (1985): 491-493.
  7. Gouveris H., et al. “Intratympanic dexamethasone with hyal­uronic acid in the treatment of idiopathic sudden sensorineu­ral hearing loss after failure of intravenous steroid and vasoac­tive therapy”. European Archives of Otorhinolaryngology 2 (2005): 131-134.
  8. Hobson CE., et al. “Primary treatment of idiopathic sudden sensorineural hearing loss with intratympanic dexametha­sone”. Current Opinion in Otolaryngology and Head and Neck Surgery 5 (2016): 407-412.
  9. Ng JH., et al. “Intratympanic steroids as a salvage treatment for sudden sensorineural hearing loss? A meta-analysis”. Eu­ropean Archives of Otorhinolaryngology 10 (2015): 2777-2782.
  10. Scott-Brown’s Otorhinolaryngology, Head and Neck Surgery, 7th edn, Table 238e.6, Intra tympanic Dexamethasone for ISSNHL.


Citation: Brajpal Tyagi and Manika Teotia. “Platelet Rich Plasma in SNHL".Acta Scientific Otolaryngology 5.3 (2023): 32-35.


Copyright: © 2022 Brajpal Tyagi and Manika Teotia. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Acceptance rate34%
Acceptance to publication20-30 days
Impact Factor0.871

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is May 30, 2024.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of "Best Article of the Issue"
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.

Contact US